111113-13-4

Upstream product

• 111113-10-1 phenylmethyl N-[2,3-dihydro-5-phenyl-2-thioxo-1H-1,4-benzodiazepin-3-yl]carbamate 
• 108895-98-3 benzyl 2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-ylcarbamate 

Downstream Products

• 111113-20-3 1-Methyl-6-phenyl-4H-[1,2,4]triazolo-[4,3-a][1,4]benzodiazepin-4-ylamine formate salt 
• 111113-18-9 6-phenyl-4H-<1,2,4>triazolo<4,3-a><1,4>benzodiazepin-4-ylamine formate salt 
• 111113-22-5 N-(4-Chlorophenyl)-N'-(1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl)urea 
• 111113-21-4 N-(4-chlorophenyl)-N'-(6-phenyl-4H-<1,2,4>triazolo<4,3-a><1,4>benzodiazepin-4-yl)urea 
• 146135-18-4 phenylmethyl (1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl)carbamate 

Relevant academic research and scientific papers

Cholestokinin Antagonists. Synthesis and Biological Evaluation of 4-Substituted 4H-Triazolobenzodiazepines

A series of 4-substituted 4H-triazolobenzodiazepines was prepared by standard metodology.These compounds were tested in vitro as antagonists of the binding of cholestokinin (CCK) to rat pancreas and guinea pig brain receptors and